Arteris Inc. raises FY26 sales guidance to $95-98M range
Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.
How this was made
The 30-second read
Why it matters
The company’s FY2026 revenue guidance is upgraded, implying stronger demand and/or better-than-expected initial license fees and royalty accruals.
Market read
A guidance raise that clears consensus can drive repricing of FY26 expectations and near-term momentum in ARTE.
What to watch
Traders may want to verify whether the guidance raise is driven by one-time license fees versus recurring royalties, and whether backlog/order inflows are sustainable into FY27.
Background
Arteris provides semiconductor intellectual property and software solutions, with revenue visibility often tied to licensing and volume-based royalties.
Market effects
A stronger NoC interconnect and design automation adoption narrative can modestly improve sentiment across semiconductor IP and EDA-adjacent names.
None indicated.
None indicated beyond semiconductor IP demand read-through.
Counterpoint
The guidance range is still a forecast, and the article does not quantify margin, cash flow, or customer concentration risk that could limit upside.
Key entities
- public_companyArteris Inc.
Semiconductor IP and software provider that raised FY2026 sales guidance to $95.0M-$98.0M.
